NRX Pharmaceuticals, Inc. (NRXP) Files Proxy Statement Ahead of Shareholder Meeting
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on February 23, 2026. The Healthcare company's…
Read more
